SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 88,500
-1,900 (-2.10%)
At close: May 12, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 6.93 trillion as of May 12, 2025. Its market cap has increased by 0.11% in one year.
Market Cap
6.93T
Enterprise Value
6.82T
Revenue
547.60B
Ranking
n/a
PE Ratio
28.79
Stock Price
88,500.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 6.93T, a decrease of -30.31%. That is a compound annual growth rate of -7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 6,930.72B | -20.34% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 70.53T |
| Celltrion | 32.36T |
| ALTEOGEN | 17.91T |
| Yuhan | 7,864.20B |
| HLB Co., Ltd. | 7,463.37B |
| PharmaResearch | 4,135.08B |
| Peptron | 3,983.85B |
| LigaChem Biosciences | 3,519.36B |